Home > Compliance Monitoring > Continuum of Quality

AIT adheres to “A Higher Standard of Service” throughout the entire client experience

AIT’s service begins at the point of care and ends with the needs of the healthcare practitioner. Our account executives provide on-site training and resources to help make the collection process seamless. Our technology and highly trained chemists ensure quality throughout the screening and confirmation process, our reports are easy to read, and available Ph.D. toxicologists stand ready to consult with you on specimen collection, drug interaction, and interpretation of results. 
 

Point of Care

• Highly trained national sales force to meet your service needs
• Hands-on, in-service training and education for offices
• Strict chain-of-custody;  adherence to College of American Pathologists (CAP) and American Board of Forensic Toxicology (ABFT) guidelines 
• Multiple options for container and transport 
• World-class shipping and logistics
• Top therapy awareness program in the industry
• Blood testing available for identification of patient’s current state

Screening

• State-of-the-art laboratory utilizing immunoassay technology
• Research and development efforts to continuously improve screening technology 
• Lowest screening cut-off levels in the industry

Confirmation

• Confirmations provide a “chemical fingerprint” for each drug confirmed

Reports & Data

• Multiple options for reporting
• Reports available through secure online portal
• East-to-read, interpretive results
• Stringent certification review that can stand in U.S. judicial system
• Randomization program capability
• Customized reporting for practice data and trend analysis
• Processes certified by:
  - International Organization for Standardization (ISO)
  - Clinical Laboratory Improvement Amendments (CLIA)
  - College of American Pathologists (CAP)
  - American Board of Forensic Toxicology (ABFT)

Questions & Analysis

• Ph.D. toxicologists available 24/7
• One-on-one consultation available for no additional charge
• Unparalleled academic and practical experience 
• Explanations available for unpublished anomalies found in high-dose patients
• Access to on-site, in-house specialized billing team
• Flexible payment plans for patients without insurance
• Quick access to interactive information about testing and results
• Multiple avenues for receiving results: phone, e-mail, Web, and fax

Want to learn more?

For more information about AIT’s DetectiMed® Panel, contact our Client Services Department or search for a sales representative in your state.

AIT Laboratories Moves Up on Inc. 5000 List

AIT Publishes Article About Compliance Monitoring and Risk Mitigation

AIT Laboratories Announces New Headquarters